These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9669295)

  • 21. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Graves' ophthalmopathy.
    Beck RW; DiLoreto DA
    N Engl J Med; 1990 Apr; 322(15):1088-9. PubMed ID: 2320076
    [No Abstract]   [Full Text] [Related]  

  • 23. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy.
    Glinoer D; Etienne-Decerf J; Schrooyen M; Sand G; Hoyoux P; Mahieu P; Winand R
    Metab Pediatr Syst Ophthalmol (1985); 1988; 11(3):133-40. PubMed ID: 3205168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive treatment of Graves' ophthalmopathy with cyclosporine A.
    Utech C; Wulle KG; Panitz N; Kiefer H
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):173-7. PubMed ID: 3381272
    [No Abstract]   [Full Text] [Related]  

  • 25. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy.
    Prummel MF; Mourits MP; Berghout A; Krenning EP; van der Gaag R; Koornneef L; Wiersinga WM
    N Engl J Med; 1989 Nov; 321(20):1353-9. PubMed ID: 2519530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of plasmapheresis in a case of Graves' disease with malignant ophthalmopathy (author's transl)].
    Glinoer D; Gaham N; Sand G; Libert J; Grivegnee A; Badjou R; Ermans AM
    Ann Endocrinol (Paris); 1981 Dec; 42(6):545-6. PubMed ID: 6896620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of HLA antigen BW35 with severe Graves' ophthalmopathy.
    Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ; Sanford CA
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):124-7. PubMed ID: 6600737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy for Graves' ophthalmopathy].
    Zheng J; Zhang X; Gong R; Wang J; Tan T
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Oct; 21(5):876-9. PubMed ID: 15553880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Graves-Basedow ophthalmopathy].
    Musch W
    Rev Med Brux; 2001 Jun; 22(3):A182-3. PubMed ID: 11488088
    [No Abstract]   [Full Text] [Related]  

  • 30. [Severe endocrine ophthalmopathy. A review with case reports].
    Barth A; Bosshard C; Bürgi U; Bürgi H
    Schweiz Med Wochenschr; 1991 Jan; 121(1-2):3-9. PubMed ID: 1899292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New approaches to the therapy of diffuse inflammatory diseases of the connective tissue].
    González T; Rodríguez-Lozano B; Hernández-Beriaín JA
    Med Clin (Barc); 1991 Oct; 97(11):424-30. PubMed ID: 1961050
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence.
    Wei RL; Cheng JW; Cai JP
    Ophthalmologica; 2008; 222(1):27-31. PubMed ID: 18097177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharma-clinics. How I treat ... thyroid ophthalmopathy].
    Joachim M; Andris C; Duchesne B
    Rev Med Liege; 1996 Jul; 51(7):449-52. PubMed ID: 8766533
    [No Abstract]   [Full Text] [Related]  

  • 34. [New therapeutic manual of malignant exophthalmos].
    Izumi M; Nagataki S
    Nihon Naibunpi Gakkai Zasshi; 1991; 67 Suppl 1():112-20. PubMed ID: 2044825
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunosuppressive treatment of Graves' ophthalmopathy.
    Wiersinga WM
    Thyroid; 1992; 2(3):229-33. PubMed ID: 1422236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of acute disseminated encephalomyelitis with plasmapheresis in a 16-year-old female, a case report and literature review.
    Yi CH; La Vega-Talbott M; Friedman MT
    J Clin Apher; 2014 Dec; 29(6):339-40. PubMed ID: 24824150
    [No Abstract]   [Full Text] [Related]  

  • 37. Initial treatment of childhood chronic inflammatory demyelinating polyradiculoneuropathy.
    Teasley JE
    Muscle Nerve; 2008 Dec; 38(6):1640-3. PubMed ID: 19125447
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma exchange therapy for severe Graves' ophthalmopathy.
    Glinoer D; Schrooyen M; Winand R
    Dev Ophthalmol; 1989; 20():91-3. PubMed ID: 2591631
    [No Abstract]   [Full Text] [Related]  

  • 39. Combined irradiation and low-dose cyclophosphamide in the treatment of Graves' ophthalmopathy.
    Teoh R; Woo J
    Postgrad Med J; 1987 Sep; 63(743):777-9. PubMed ID: 3444803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy.
    Utech CI; Khatibnia U; Winter PF; Wulle KG
    Thyroid; 1995 Jun; 5(3):185-93. PubMed ID: 7580266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.